- The Grant for Multiple Sclerosis Innovation (GMSI) was first launched at the 28th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in October 2012.
- The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programs, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.
- A total grant of up to €1,000,000 will be awarded to one or more selected projects.
- Applications are invited from around the world and will be reviewed by the Scientific Committee against the following criteria:
- Relevance to clinical practice
- Innovative research
- Scientific rationale
- Practical utility
The four award winners of the first GMSI were announced during the satellite symposium at the 29th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, on Saturday, October 5, 2013.
The five award winners of the second GMSI were announced during the satellite symposium at the 2014 Joint ACTRIMS-ECTRIMS Meeting held in Boston, USA, on Friday, September 12, 2014.
The four award winners of the third GMSI were announced during an award ceremony that took place to coincide with the 31st ECTRIMS congress in Barcelona, Spain, on Thursday, October 8, 2015.
The four award winners of the fourth GMSI were announced during an award
ceremony that took place to coincide with the 3
2nd ECTRIMS congress in London,
England, on Thursday, September 15, 2016.